GENE ONLINE|News &
Opinion
Blog

Deals
COVID-19 Moderna
Moderna to Supply 66 Million COVID-19 Boosters to US
2022-07-29
Licensing Merck
Oncology Research Collaboration between Kelun-Biotech and MSD
2022-07-27
Asia-Pacific Hong Kong
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Partnerships Liver Disease
Verve and Vertex Agree to Co-Develop In Vivo Gene Editing Program for Liver Disease
2022-07-21
Licensing F-star
Takeda Throws $1 Million at F-star to Develop Bispecific Antibody For Novel Cancer Therapies
2022-07-21
Partnerships Roche
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
Partnerships Nestlé Health Science
Nestlé Lays Down €40 Million on Enterome’s Food Allergy and IBD Candidate
2022-07-19
Funding Series B Funding
Delfi Diagnostics Amasses $225 Million for Early Cancer Screening
2022-07-19
Deals Trelegy Ellipta
Troubled Theravance Offloads Rights To Top Asset To Royalty Pharma For $1.5 Billion
2022-07-15
Partnerships Oncology
Orion Collects $290 Million From Merck in Prostate Cancer Development Collaboration
2022-07-14
Licensing IONIS-FB-LRx
Roche Receives Rights to Ionis’ Antisense Kidney Disease Drug for $55 Million
2022-07-12
Trials & Approvals mRNA Vaccine
NIH Launches mRNA Nipah Virus Vaccine Trial With Moderna
2022-07-12
Licensing Oncology
ADC Therapeutics and Sobi Sign $435 Million Deal to Expand Blood Cancer Drug’s Market
2022-07-11
China Series B Funding
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
M&A Merck
Merck Reportedly Interested in Potential $40 Billion SeaGen Buyout
2022-07-08
1 … 15 16 17 18 19 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top